The CG + GG genotype of XRCC6 rs2267437 was associated with an increased risk of ER−/PR− breast cancer (CG + GG vs. CC: OR = 1.54, 95% CI = 1.12–2.13, p = 0.008) after Bonferroni correction. This evidence concerns the gene XRCC6 and breast carcinoma.